BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8866230)

  • 1. High-sensitivity detection of minimal residual breast carcinoma using the polymerase chain reaction and primers for cytokeratin 19.
    Moscinski LC; Trudeau WL; Fields KK; Elfenbein GJ
    Diagn Mol Pathol; 1996 Sep; 5(3):173-80. PubMed ID: 8866230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction.
    Datta YH; Adams PT; Drobyski WR; Ethier SP; Terry VH; Roth MS
    J Clin Oncol; 1994 Mar; 12(3):475-82. PubMed ID: 7509852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation.
    Fields KK; Elfenbein GJ; Trudeau WL; Perkins JB; Janssen WE; Moscinski LC
    J Clin Oncol; 1996 Jun; 14(6):1868-76. PubMed ID: 8656255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of molecular cytokeratin 19 reverse transcriptase polymerase chain reaction (CK19 RT-PCR) and immunocytochemical detection of micrometastatic breast cancer cells in hematopoietic harvests.
    Traystman MD; Cochran GT; Hake SJ; Kuszynski CA; Mann SL; Murphy BJ; Pirruccello SJ; Zuvanich E; Sharp JG
    J Hematother; 1997 Dec; 6(6):551-61. PubMed ID: 9483190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19.
    Schoenfeld A; Kruger KH; Gomm J; Sinnett HD; Gazet JC; Sacks N; Bender HG; Luqmani Y; Coombes RC
    Eur J Cancer; 1997 May; 33(6):854-61. PubMed ID: 9291805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin gene.
    Luppi M; Morselli M; Bandieri E; Federico M; Marasca R; Barozzi P; Ferrari MG; Savarino M; Frassoldati A; Torelli G
    Ann Oncol; 1996 Aug; 7(6):619-24. PubMed ID: 8879377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of breast tumour cell contamination in the bone marrow and leukapheresis collections by RT-PCR for cytokeratin-19 mRNA.
    Vannucchi AM; Bosi A; Glinz S; Pacini P; Linari S; Saccardi R; Alterini R; Rigacci L; Guidi S; Lombardini L; Longo G; Mariani MP; Rossi-Ferrini P
    Br J Haematol; 1998 Dec; 103(3):610-7. PubMed ID: 9858208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reverse transcriptase/polymerase chain reaction analysis of parathyroid hormone-related protein for the detection of tumor cell dissemination in the peripheral blood and bone marrow of patients with breast cancer.
    Wulf GG; Jürgens B; Liersch T; Gatzemeier W; Rauschecker H; Buske C; Hüfner M; Hiddemann W; Wörmann B
    J Cancer Res Clin Oncol; 1997; 123(9):514-21. PubMed ID: 9341902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of nonmelanoma skin cancer micrometastases in lymph nodes by using reverse transcriptase-polymerase chain reaction for keratin 19 mRNA.
    Kamiya M; Ichiki Y; Kamiya H; Yamamoto A; Kitajima Y
    Br J Dermatol; 2003 Nov; 149(5):998-1005. PubMed ID: 14632805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow.
    Zippelius A; Kufer P; Honold G; Köllermann MW; Oberneder R; Schlimok G; Riethmüller G; Pantel K
    J Clin Oncol; 1997 Jul; 15(7):2701-8. PubMed ID: 9215843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of circulating cancer cells by nested reverse transcription-polymerase chain reaction of cytokeratin-19 (K19)--possible clinical significance in advanced gastric cancer.
    Yeh KH; Chen YC; Yeh SH; Chen CP; Lin JT; Cheng AL
    Anticancer Res; 1998; 18(2B):1283-6. PubMed ID: 9615802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal illegitimate levels of cytokeratin K19 expression in mononucleated blood cells detected by a reverse transcription PCR method (RT-PCR).
    López-Guerrero JA; Bolufer-Gilabert P; Sanz-Alonso M; Barragán-González E; Palau-Pérez J; De la Rubia-Comos J; Sempere-Talens A; Bonanad-Boix S
    Clin Chim Acta; 1997 Jul; 263(1):105-16. PubMed ID: 9247732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of sensitivity and specificity of cytokeratin 19 reverse transcriptase/polymerase chain reaction for detection of occult breast cancer in bone marrow and leukapheresis products.
    Zhong XY; Kaul S; Diel I; Eichler A; Bastert G
    J Cancer Res Clin Oncol; 1999; 125(5):286-91. PubMed ID: 10359133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative molecular detection of minimal residual head and neck cancer in lymph node aspirates.
    Nieuwenhuis EJ; Jaspars LH; Castelijns JA; Bakker B; Wishaupt RG; Denkers F; Leemans CR; Snow GB; Brakenhoff RH
    Clin Cancer Res; 2003 Feb; 9(2):755-61. PubMed ID: 12576446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific detection of cytokeratin 20-positive cells in blood of colorectal and breast cancer patients by a high sensitivity real-time reverse transcriptase-polymerase chain reaction method.
    Giribaldi G; Procida S; Ulliers D; Mannu F; Volpatto R; Mandili G; Fanchini L; Bertetto O; Fronda G; Simula L; Rimini E; Cherchi G; Bonello L; Maule MM; Turrini F
    J Mol Diagn; 2006 Feb; 8(1):105-12. PubMed ID: 16436641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reverse transcriptase-polymerase chain reaction analysis of cytokeratin 19 expression in the peripheral blood mononuclear cells of normal female blood donors.
    Novaes M; Bendit I; Garicochea B; del Giglio A
    Mol Pathol; 1997 Aug; 50(4):209-11. PubMed ID: 9350305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a sensitive, highly controlled assay for molecular detection of the Philadelphia chromosome in patients with chronic myelogenous leukemia.
    Hessner MJ; Roth MS; Drobyski WR; Baxter-Lowe LA
    Genet Anal Tech Appl; 1994; 11(4):90-4. PubMed ID: 7857690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-time analysis of tyrosine hydroxylase gene expression: a sensitive and semiquantitative marker for minimal residual disease detection of neuroblastoma.
    Lambooy LH; Gidding CE; van den Heuvel LP; Hulsbergen-van de Kaa CA; Ligtenberg M; Bökkerink JP; De Abreu RA
    Clin Cancer Res; 2003 Feb; 9(2):812-9. PubMed ID: 12576454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of competitive-nested PCR and real-time PCR in detecting BCR-ABL fusion transcripts in chronic myeloid leukemia patients.
    Guo JQ; Lin H; Kantarjian H; Talpaz M; Champlin R; Andreeff M; Glassman A; Arlinghaus RB
    Leukemia; 2002 Dec; 16(12):2447-53. PubMed ID: 12454751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Comparison between MUC1 mRNA and keratin 19 mRNA amplification.
    Noguchi S; Aihara T; Motomura K; Inaji H; Imaoka S; Koyama H
    Am J Pathol; 1996 Feb; 148(2):649-56. PubMed ID: 8579127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.